Johnson & Johnson To Discontinue Late-Stage Study Of Experimental RSV Vaccine

Reuters (3/29, Leo, Erman) reports, “Johnson & Johnson said it will discontinue the late-stage study of its experimental respiratory syncytial virus adult vaccine, weeks after rivals Pfizer and GSK gained a lead in the race for the first vaccine against t...